These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 2842395
1. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. Liang XP, Lamm ME, Nedrud JG. J Immunol; 1988 Sep 01; 141(5):1495-501. PubMed ID: 2842395 [Abstract] [Full Text] [Related]
3. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice. Liang XP, Lamm ME, Nedrud JG. Reg Immunol; 1989 Nov 15; 2(4):244-8. PubMed ID: 2561961 [Abstract] [Full Text] [Related]
4. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased. Nedrud JG, Sigmund N. Reg Immunol; 1989 Nov 15; 3(5):217-22. PubMed ID: 1966580 [Abstract] [Full Text] [Related]
5. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K. Microbiol Immunol; 2008 Feb 15; 52(2):55-63. PubMed ID: 18380802 [Abstract] [Full Text] [Related]
6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Am J Trop Med Hyg; 1994 Feb 15; 50(5 Suppl):42-54. PubMed ID: 8203723 [Abstract] [Full Text] [Related]
7. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2. Drew MD, Estrada AE, Underdown BJ, McDermott MR. Reg Immunol; 1992 Feb 15; 4(2):79-85. PubMed ID: 1503890 [Abstract] [Full Text] [Related]
8. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Tamura S, Funato H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T. Eur J Immunol; 1991 Jun 15; 21(6):1337-44. PubMed ID: 1646112 [Abstract] [Full Text] [Related]
10. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response. Chen KS, Strober W. Eur J Immunol; 1990 Feb 15; 20(2):433-6. PubMed ID: 2311649 [Abstract] [Full Text] [Related]
12. Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. Mazanec MB, Nedrud JG, Liang XP, Lamm ME. J Immunol; 1989 Jun 15; 142(12):4275-81. PubMed ID: 2542407 [Abstract] [Full Text] [Related]
13. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A. J Virol; 2006 Feb 15; 80(4):1752-61. PubMed ID: 16439532 [Abstract] [Full Text] [Related]
14. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Strindelius L, Filler M, Sjöholm I. Vaccine; 2004 Sep 09; 22(27-28):3797-808. PubMed ID: 15315861 [Abstract] [Full Text] [Related]
15. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. Imaoka K, Miller CJ, Kubota M, McChesney MB, Lohman B, Yamamoto M, Fujihashi K, Someya K, Honda M, McGhee JR, Kiyono H. J Immunol; 1998 Dec 01; 161(11):5952-8. PubMed ID: 9834076 [Abstract] [Full Text] [Related]
16. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques. Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF. Vaccine; 2004 Sep 09; 22(27-28):3774-88. PubMed ID: 15315859 [Abstract] [Full Text] [Related]
17. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice. Nyström-Asklin J, Adamsson J, Harandi AM. Scand J Immunol; 2008 May 09; 67(5):431-40. PubMed ID: 18298617 [Abstract] [Full Text] [Related]
18. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. Snider DP, Marshall JS, Perdue MH, Liang H. J Immunol; 1994 Jul 15; 153(2):647-57. PubMed ID: 8021502 [Abstract] [Full Text] [Related]
19. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice. Sasaki K, Kato M, Takahashi T, Ochi S, Ichinose Y, Shiraki K, Asano Y, Iwanaga M, Tsuji T. J Med Virol; 2003 Jun 15; 70(2):329-35. PubMed ID: 12696126 [Abstract] [Full Text] [Related]
20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]